Moreover, FXR plays a crucial and beneficial role in glucose metabolism and in the regulation of bile acid homeostasis, and FXR agonists are promising for the treatment of NAFLD, dyslipidemia, and type 2 diabetes [50]. This evidence concerns the gene NR1H4 and metabolic dysfunction-associated steatotic liver disease.